4//SEC Filing
Violette Shelia M. 4
Accession 0000950170-24-114051
CIK 0001661998other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:05 PM ET
Size
7.8 KB
Accession
0000950170-24-114051
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Violette Shelia M.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-10-08$3.12/sh+13,300$41,496→ 13,300 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-08−13,300→ 213 totalExercise: $3.12Exp: 2028-12-06→ Common Stock (13,300 underlying)
Holdings
- 36,277(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.
- [F2]The shares underlying this option are fully vested and exercisable as of the date hereof.
Documents
Issuer
Q32 Bio Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0002016144
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 4:05 PM ET
- Size
- 7.8 KB